FDA inspection
Suzhou Suncadia Biopharmaceuticals Co., Ltd: FDA inspection ending Dec 14, 2023
FDA inspection 1242894 · Official Action Indicated (OAI) · Suzhou
Key facts
| Inspection ID | 1242894 |
|---|---|
| Firm | Suzhou Suncadia Biopharmaceuticals Co., Ltd |
| FEI number | 3015786877 |
| Address | Suzhou Industrial Park, No 350 Fengli St |
| City | Suzhou |
| Fiscal year | 2024 |
| Inspection end date | Dec 14, 2023 |
| Classification | Official Action Indicated (OAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data